Weekly Recap

Blarcamesine Exceeds Enrollment, Higher Plasma Nusinersen Leads to Meaningful Improvements, Neurodevelopmental Outcomes Unchanged by Maternal ASMs

ByNeurologyLive® Staff

June 19th 2021

Neurology News Network for the week ending June 19, 2021.

Telemedicine Produces Meaningful Migraine Improvement, Galcanezumab Shows No Wearing Effect, CGRPs All Significant Improve MMDs

ByNeurologyLive® Staff

June 12th 2021

Neurology News Network for the week ending June 12, 2021.

Experts Call for Better Trial Design, Alzheimer Disease Vaccine Shows Safety, FDA Accepts IND for LION-101

ByNeurologyLive® Staff

June 5th 2021

Neurology News Network for the week ending June 5, 2021.

ANVS401 Shows Promise in Alzheimer Disease, FDA Approves IND for Ketamine in Parkinson, MedRhythms Collaborates With Massachusetts General Hospital

ByNeurologyLive® Staff

May 29th 2021

Neurology News Network for the week ending May 29, 2021.

ET Associated With Substantial HCRU, MS Phenotypes Share Common Mechanisms, Hypertension Risk in Menopausal Women With Migraine

ByNeurologyLive® Staff

May 22nd 2021

Neurology News Network for the week ending May 22, 2021.

Gene Therapy in SLC13A5 Deficiency, DMTs Reduce Risk of Disability in Pediatric MS, FASTEST Phase 3 Study Announced

ByNeurologyLive® Staff

May 15th 2021

Neurology News Network for the week ending May 15, 2021.

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

ByNeurologyLive® Staff

May 8th 2021

Neurology News Network for the week ending May 8, 2021.

Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses

ByNeurologyLive® Staff

May 1st 2021

Neurology News Network for the week ending May 1, 2021.

Stroke Common Cause of Seizures, Inebilizumab Demonstrates Continued Benefits, Fremanezumab Safe in Patients With CV Risk

ByNeurologyLive® Staff

April 24th 2021

Neurology News Network for the week ending April 24, 2021.

Risdiplam Demonstrates Continued Improvements in SMA, Cortical Hyperexcitability in ALS, Retinal Atrophy Modulated With Rituximab

ByNeurologyLive® Staff

April 17th 2021

Neurology News Network for the week ending April 17, 2021.

RESILIENT Long-Term Extension Data, Associations Between Abuse and Migraine, Retinal Biomarkers in Alzheimer Disease

ByNeurologyLive® Staff

April 10th 2021

Neurology News Network for the week ending April 10, 2021.

HD Treatment Tominsersen Discontinued, FDA Approves Atogepant NDA, NurOwn's Promising Results in Progressive MS

ByNeurologyLive® Staff

April 3rd 2021

Neurology News Network for the week ending April 3, 2021.

Racial Disparities in EVT Access, Forced Exercise Impact on Poststroke Patients, EVT Benefits Within 24 Hour Window

ByNeurologyLive® Staff

March 27th 2021

Neurology News Network for the week ending March 27, 2021.

Risdiplam in Symptomatic SMA, Nusinersen Preserves Swallowing, Ataluren Delays Ambulation in DMD

ByNeurologyLive® Staff

March 20th 2021

Neurology News Network for the week ending March 20, 2021.

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

ByNeurologyLive® Staff

March 13th 2021

Neurology News Network for the week ending March 13, 2021.

Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term

ByNeurologyLive® Staff

March 6th 2021

Neurology News Network for the week ending March 6, 2021.

Siponimod Improves Cognitive Processing Speed, Opioid Use for Migraine in Emergency Departments, Reduced Stroke Admissions During Pandemic

ByNeurologyLive® Staff

February 27th 2021

Neurology News Network for the week ending February 27, 2021.

JZP-258 sNDA Accepted, FDA Clears gammaCore nVNS, Prevalence of Seizure Cycles

ByNeurologyLive® Staff

February 20th 2021

Neurology News Network for the week ending February 20, 2021.

FDA Approves Genio OSA Therapy, Improved Motor Function With FUS, Soticlestat Evaluated in Dravet Sydrome

ByNeurologyLive® Staff

February 13th 2021

Neurology News Network for the week ending February 13, 2021.

Rituximab Suppresses Inflammatory Disease in MS, IND Filed for ImmCelz, Laser Ablation Safe in Focal Epilepsy

ByNeurologyLive® Staff

February 6th 2021

Neurology News Network for the week ending February 6, 2021.

FDA Grants BREN-02 Orphan Drug Designation, Memory Preservation in Primary Progressive Aphasia, Phenotypes of MS

ByNeurologyLive® Staff

January 30th 2021

Neurology News Network for the week ending January 30, 2021.

FDA Approves TBI Blood Test, Causal Link Between Smoking and Subarachnoid Hemorrhage, Inconsistencies Across EEG Education

ByNeurologyLive® Staff

January 23rd 2021

Neurology News Network for the week ending January 23, 2021.

Donanemab Shows Decline in Alzheimer, Pfizer DMD Study Launched, REM Not Correlated With Seizures

ByNeurologyLive® Staff

January 16th 2021

Neurology News Network for the week ending January 16, 2021.

FDA Approves EEG System, Neurologic Diagnostic Out-Of-Pocket Costs Rising, Nerivio Safe for Adolescents With Migraine

ByNeurologyLive® Staff

January 9th 2021

Neurology News Network for the week ending January 9, 2021.

Larger Infarct Volume Associated With Poorer Outcomes, Edavarone Shows Efficacy in ALS, DMD Treatment Demonstrates Proof-Of-Concept

ByNeurologyLive® Staff

January 2nd 2021

Neurology News Network for the week ending January 2, 2021.

CBD Transdermal Gel Reduces Seizure Frequency, nVNS Improves Migraine, EDSS Accuracy Improvised

ByNeurologyLive® Staff

December 26th 2020

Neurology News Network for the week ending December 26, 2020.

FDA Approves Shorter-Infusion Ocrelizumab, StrokeViewer Cleared by FDA, Ezogabine Demonstrates Efficacy in ALS

ByNeurologyLive® Staff

December 19th 2020

Neurology News Network for the week ending December 19, 2020.

CBD Effective Regardless of Infantile Spasm History, Fenfluramine Effective in CDD, Wristband Sensor Data May Predict Seizures

ByNeurologyLive® Staff

December 12th 2020

Neurology News Network for the week ending December 12, 2020.

Smartphone PMR Treats Migraine, NMOSD Relapse in Pregnant Women, FDA Grants ALS Agent Orphan Drug Designation

ByNeurologyLive® Staff

December 5th 2020

Neurology News Network for the week ending December 5, 2020.

NDA For INP104 Submitted, Sodium Oxybate Improves Nocturnal RBD, Health-Deficit Accumulation Leads to Cognitive Impairment

ByNeurologyLive® Staff

November 28th 2020

Neurology News Network for the week ending November 28, 2020.

Weekly Recap

Blarcamesine Exceeds Enrollment, Higher Plasma Nusinersen Leads to Meaningful Improvements, Neurodevelopmental Outcomes Unchanged by Maternal ASMs

Telemedicine Produces Meaningful Migraine Improvement, Galcanezumab Shows No Wearing Effect, CGRPs All Significant Improve MMDs

Experts Call for Better Trial Design, Alzheimer Disease Vaccine Shows Safety, FDA Accepts IND for LION-101

ANVS401 Shows Promise in Alzheimer Disease, FDA Approves IND for Ketamine in Parkinson, MedRhythms Collaborates With Massachusetts General Hospital

ET Associated With Substantial HCRU, MS Phenotypes Share Common Mechanisms, Hypertension Risk in Menopausal Women With Migraine

Gene Therapy in SLC13A5 Deficiency, DMTs Reduce Risk of Disability in Pediatric MS, FASTEST Phase 3 Study Announced

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses

Stroke Common Cause of Seizures, Inebilizumab Demonstrates Continued Benefits, Fremanezumab Safe in Patients With CV Risk

Risdiplam Demonstrates Continued Improvements in SMA, Cortical Hyperexcitability in ALS, Retinal Atrophy Modulated With Rituximab

RESILIENT Long-Term Extension Data, Associations Between Abuse and Migraine, Retinal Biomarkers in Alzheimer Disease

HD Treatment Tominsersen Discontinued, FDA Approves Atogepant NDA, NurOwn's Promising Results in Progressive MS

Racial Disparities in EVT Access, Forced Exercise Impact on Poststroke Patients, EVT Benefits Within 24 Hour Window

Risdiplam in Symptomatic SMA, Nusinersen Preserves Swallowing, Ataluren Delays Ambulation in DMD

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term

Siponimod Improves Cognitive Processing Speed, Opioid Use for Migraine in Emergency Departments, Reduced Stroke Admissions During Pandemic

JZP-258 sNDA Accepted, FDA Clears gammaCore nVNS, Prevalence of Seizure Cycles

FDA Approves Genio OSA Therapy, Improved Motor Function With FUS, Soticlestat Evaluated in Dravet Sydrome

Rituximab Suppresses Inflammatory Disease in MS, IND Filed for ImmCelz, Laser Ablation Safe in Focal Epilepsy

FDA Grants BREN-02 Orphan Drug Designation, Memory Preservation in Primary Progressive Aphasia, Phenotypes of MS

FDA Approves TBI Blood Test, Causal Link Between Smoking and Subarachnoid Hemorrhage, Inconsistencies Across EEG Education

Donanemab Shows Decline in Alzheimer, Pfizer DMD Study Launched, REM Not Correlated With Seizures

FDA Approves EEG System, Neurologic Diagnostic Out-Of-Pocket Costs Rising, Nerivio Safe for Adolescents With Migraine

Larger Infarct Volume Associated With Poorer Outcomes, Edavarone Shows Efficacy in ALS, DMD Treatment Demonstrates Proof-Of-Concept

CBD Transdermal Gel Reduces Seizure Frequency, nVNS Improves Migraine, EDSS Accuracy Improvised

FDA Approves Shorter-Infusion Ocrelizumab, StrokeViewer Cleared by FDA, Ezogabine Demonstrates Efficacy in ALS

CBD Effective Regardless of Infantile Spasm History, Fenfluramine Effective in CDD, Wristband Sensor Data May Predict Seizures

Smartphone PMR Treats Migraine, NMOSD Relapse in Pregnant Women, FDA Grants ALS Agent Orphan Drug Designation

NDA For INP104 Submitted, Sodium Oxybate Improves Nocturnal RBD, Health-Deficit Accumulation Leads to Cognitive Impairment

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

International Committee Publishes 2024 Revisions to McDonald Diagnostic Criteria for Multiple Sclerosis

SKY-0515 Demonstrates Dose-Dependent Reductions in Mutant Huntingtin Protein in Phase 1 Update

New Study Finds Link Between Gut Hormone GLP-1 and NMOSD Symptoms, Paving Way for Targeted Treatments

RELIEV-CM Pilot Study Data Further Supports ShiraTronics’ Neuromodulation Device to Treat Chronic Migraine

Exploring the Unmet Need for FDA-Approved Therapies in Stuttering: Gerald McGuire, MD